Edition:
India

Xvivo Perfusion AB (XVIVO.ST)

XVIVO.ST on Stockholm Stock Exchange

148.40SEK
24 Sep 2018
Change (% chg)

-4.00kr (-2.62%)
Prev Close
152.40kr
Open
152.40kr
Day's High
152.40kr
Day's Low
146.60kr
Volume
24,689
Avg. Vol
39,893
52-wk High
169.00kr
52-wk Low
82.00kr

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 46.09 0.148
Mar '18 42.47 0.145
FY 2017 Dec '17 41.57 0.211
Sep '17 32.26 -0.013
Jun '17 37.03 0.042
Mar '17 37.48 -0.002
FY 2016 Dec '16 38.42 -0.025
Sep '16 31.73 -0.023
Jun '16 34.50 0.071
Mar '16 33.53 0.052
 
*Note: Units in Millions ofSwedish Krona
**Note: Units in Swedish Krona

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 46.33 49.00 44.00 --
Quarter Ending Dec-18 3 59.33 63.00 54.00 --
Year Ending Dec-18 3 194.00 200.00 187.00 208.00
Year Ending Dec-19 3 282.33 306.00 237.00 295.50
Earnings (per share)
Quarter Ending Sep-18 3 0.15 0.29 0.04 --
Quarter Ending Dec-18 3 0.37 0.52 0.21 --
Year Ending Dec-18 3 0.81 1.10 0.53 0.90
Year Ending Dec-19 3 1.72 2.37 1.13 1.93
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 14.91 26.09 --
EPS (TTM) % -72.38 -45.71 --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Xvivo Perfusion AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 4.44 -- 99 --
13 Week -2.59 -- 99 --
26 Week 9.62 -- 99 --
52 Week 24.09 -- 99 --
YTD 6.82 -- 99 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 45.21%
# of Holders: 18
Total Shares Held: 11,841,651
3 Mo. Net Change: -51,285
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 3
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.